Last Updated: 23 April 2026
Axon Enterprise, Inc. (NASDAQ: AXON) — the company formerly known as TASER International — is the dominant US public-safety platform across conducted electrical weapons, body-worn cameras, in-car cameras, drones, robotics, counter-UAS and a fast-growing cloud SaaS stack (digital evidence, records management, real-time operations, AI). FY2025 results released 24 February 2026 showed revenue $2.78bn (+33%), Software & Services $1.20bn (+40%), Connected Devices $1.58bn (+29%), ARR $1.35bn (+35%) at 125% net retention, future contracted bookings $14.4bn (+43%) and a fresh long-range target of ~$6bn revenue with ~28% adjusted EBITDA margin by 2028. FY2026 guidance: revenue growth 27–30% (~$3.5–3.6bn) and 25.5% adjusted EBITDA margin. Axon Week 2026 (Nashville, 7 April) launched three new AI products — Axon Vision (live-video AI triage), Axon Assistant (CJIS-compliant officer copilot) and Axon 911 (cloud 911 platform combining Prepared and Carbyne). The stock has compressed sharply from its 52-week high of $885.92 to $404.92 on 21 April 2026 (−54% from the high; −27% over 52 weeks), and Q1 2026 earnings hit on 6 May 2026. This research pulls together segment mix, financials, competitive position and the latest 48-hour news entirely from Axon’s own SEC filings, earnings releases and press releases — no analyst opinions, no price targets. For live charts and watchlists see our live charts, the economic calendar, and the community forum.
1. Company Snapshot
| Name | Axon Enterprise, Inc. |
| Ticker | NASDAQ: AXON (CIK 1069183) |
| Sector | Public-safety technology — law-enforcement hardware (CEW, cameras, drones, robotics) and cloud software (DEMS / RMS / RTCC / AI / 911) |
| Headquarters | 17800 N. 85th Street, Scottsdale, Arizona |
| Founded | 1993 as TASER International by Patrick W. "Rick" Smith and brother Thomas P. Smith; renamed Axon Enterprise, Inc. April 2017 |
| CEO / Founder | Patrick W. "Rick" Smith |
| COO & CFO | Brittany Bagley (CFO since August 2022, expanded to COO in 2023) |
| President | Josh Isner (since 2022; former CRO) |
| CTO & CPO | Jeff Kunins |
| Employees | ~4,100 at 12/31/2024 per 10-K (third-party estimates 5,000+ post-Dedrone/Prepared/Carbyne) |
| FY2025 revenue | $2.78 billion (+33%) |
| FY2025 ARR | $1.35 billion (+35%) |
| Future contracted bookings | $14.4 billion (+43%) at year-end 2025 |
| Adjusted EBITDA margin (FY25) | 25.5% (~$710m) |
| Market cap (21 Apr 2026) | ~$32.3–32.7 billion at $404.92 |
| Website | axon.com | IR: investor.axon.com |
2. Bull Case vs Bear Case
Bull Case
- Categorical leader across CEW (~95% global share), US police body-worn cameras (~85% share in major US cities) and digital evidence (Axon Evidence is the category-defining product).
- FY2025 revenue $2.78bn (+33%) — third consecutive year of 30%+ growth. Software & Services +40%; Connected Devices +29%.
- ARR $1.35bn (+35%); net revenue retention 125%; future contracted bookings $14.4bn (+43%) provide multi-year visibility.
- FY2026 guide: revenue growth 27–30% (~$3.5–3.6bn); adjusted EBITDA margin 25.5%. 2028 target ~$6bn revenue at ~28% adj. EBITDA margin and ~60% EBITDA-to-FCF conversion.
- AI ramp monetising: Draft One (AI-drafted police-report narratives, launched April 2024) at $30+ ARPU/month; Axon Vision, Axon Assistant and Axon 911 launched at Axon Week April 2026.
- Federal expansion accelerating: ICE 5-year TASER procurement (up to $220m, 17,800 units) approved 2026; UK Home Office approved TASER 10 for UK policing in October 2025; growing footprint in DHS, U.S. Marshals.
Bear Case
- Stock down ~54% from 52-week high ($885.92) to $404.92 on 21 April 2026 (−27% trailing 52 weeks; −12% over the trailing month).
- Trailing GAAP P/E ~250–310x; multiples rich even after the drawdown; sensitive to any growth disappointment.
- Connected Devices Q4 2025 adjusted gross margin fell ~290bps YoY to 49.3% on "product mix and global tariffs" — hardware margin pressure is structural, not just timing.
- Civil-liberties / political risk: ICE work has drawn public/municipal pushback. EFF report "Axon’s Draft One Is Designed to Defy Transparency" (July 2025); ACLU criticism; California SB 524 (2026) requires AI disclosure in police narratives. Lobbying spend tripled from $0.48m (2020) to $2.5m (2025).
- Rapid M&A pace — Prepared (~$800m), Carbyne (~$625m), Dedrone, Sky-Hero, Fusus — elevates execution and goodwill risk.
- Stock-based compensation guided to $590–620m in FY2026 — sizeable share-count dilution driver.
- Founder/CEO key-person concentration on Rick Smith.
3. What Does Axon Actually Do?
Axon sells an integrated public-safety ecosystem to law enforcement, corrections, federal agencies, military and private security. Two reportable segments:
| Segment (FY2025) | Revenue | % of total | YoY growth |
|---|---|---|---|
| Connected Devices (hardware) | $1.58bn | 56.8% | +29% |
| Software & Services (cloud SaaS) | $1.20bn | 43.2% | +40% |
| Total | $2.78bn | 100% | +33% |
Connected Devices (hardware): TASER 10 conducted electrical weapon (flagship; ramping); Axon Body 4 body-worn camera (LTE streaming, Respond-ready); Axon Fleet 3 in-car / ALPR; Signal Sidearm holster sensor; Axon Air / Skydio drone partnership; Sky-Hero indoor tactical robotics (acquired 2024); Dedrone counter-UAS portfolio (DedroneCity, Portable, RapidResponse, DedroneDefender 2 — acquired 2024); VR training (TASER 10 simulator); Fusus real-time operations (acquired 2024).
Software & Services (cloud SaaS): Axon Evidence (formerly Evidence.com, the category-defining digital evidence management product); Axon Records (RMS); Axon Standards (early-warning / professional standards); Axon Dispatch; Axon Respond (real-time crime center / live streaming); Axon AI — Draft One (AI-drafted report narratives, launched 23 April 2024), Axon Assistant (CJIS-compliant officer copilot, expanded April 2026), Axon Vision (live-video AI triage, announced April 2026), Axon 911 (cloud 911 platform combining Prepared + Carbyne, announced April 2026).
Customer base: Axon serves the majority of US state/local law enforcement (~85% share in major US cities for body-worn cameras; near-universal share in CEWs). Federal footprint accelerating (ICE, DHS, FBI, DEA, US Marshals). International present in UK (TASER 10 approved Oct 2025), Australia, Canada, Germany and the Nordics. Geographic split (% international) not separately disclosed in FY2025 release; 10-K filed early 2026 contains the geographic note.
4. The Business Model
- Razor / razorblade with 5-year enterprise contracts. Axon bundles hardware + software into multi-year "Officer Safety Plans" (OSP) and premium tiers (OSP 7, OSP 10, OSP Premier). Customers pay per-officer-per-month with hardware refresh cycles baked in.
- ARR / subscription engine. FY2025 ARR $1.35bn (+35%); net revenue retention 125%. Subscription + services >60% of revenue.
- Bookings leverage. FY2025 annual bookings $7.4bn (+46%); future contracted bookings $14.4bn (+43%) at year-end giving multi-year visibility.
- Margin profile. Q4 2025 adjusted gross margin: Software & Services 76.7% (software-only >80%); Connected Devices 49.3% (down from 52.2% on mix and global tariffs).
- TAM expansion vectors (explicit company framing): AI (Draft One, Assistant, Vision); communications/radios (Axon Body with integrated comms positioned to displace legacy LMR radios); drones & counter-drones (Skydio partner + owned Sky-Hero/Dedrone); real-time operations / 911 (Prepared ~$800m + Carbyne ~$625m acquired 2025); federal, corrections, international, private security.
- Long-term targets (set at Q4 2025 release): ~$6bn revenue by 2028 with ~28% adjusted EBITDA margin and ~60% EBITDA-to-FCF conversion.
5. Financial Health
Annual revenue (GAAP, source: Axon earnings releases)
| FY | Revenue | YoY |
|---|---|---|
| 2020 | $681m | — |
| 2021 | $863m | +27% |
| 2022 | $1.19bn | +38% |
| 2023 | $1.56bn | +31% |
| 2024 | $2.08bn (reported $2.1bn) | +33% |
| 2025 | $2.78bn | +33% |
FY2025 full-year (released 24 February 2026): revenue $2.78bn (+33%); GAAP net income $124.7m (4.5% margin); non-GAAP net income $564m (20.3% margin); adjusted EBITDA $710m (25.5% margin); operating cash flow $217m in Q4; full-year free cash flow $155m; cash & short-term investments $1.7bn at 12/31/2025; ARR $1.35bn (+35%); NRR 125%; future contracted bookings $14.4bn (+43%).
Quarterly trend (2025 source: Axon earnings releases)
| Quarter | Revenue | YoY | Software & Services | Connected Devices |
|---|---|---|---|---|
| Q1 2025 | $604m | +31% | $263m (+39%) | $341m (+26%) |
| Q2 2025 | $669m | +33% | $292m (+39%) | $376m (+29%) |
| Q3 2025 | $711m | +31% | $305m (+41%) | $405m (+24%) |
| Q4 2025 | $797m | +39% | $342.5m (+40%) | $454.2m (+38%) |
Within Connected Devices (Q3 2025 disclosure): TASER ~$238m, Personal Sensors (cameras) ~$107m, Platform Solutions (Fleet/drones/VR/Dedrone/Fusus) ~$61m. Shares outstanding: ~82.4m as of early 2026.
6. Valuation & Market Data
| Metric | Value | Notes / source date |
|---|---|---|
| Share price | $404.92 | Close 21 April 2026 |
| Market cap | ~$32.3–32.7bn | 21 April 2026 |
| 52-week high | $885.92 | |
| 52-week low | $339.01 | |
| Trailing P/E (GAAP) | ~250–310x | Modest GAAP NI ($124.7m FY25); high SBC and amortisation |
| Forward P/E | ~51x | Consensus 12-month forward |
| P/S (TTM) | ~11–12x | $2.78bn revenue, ~$32.5bn cap |
| EV/EBITDA (TTM, GAAP) | ~445x | Trailing GAAP basis; forward adj. EBITDA ~30–35x on FY26 guide |
| Dividend | None | |
| Short interest | 2.82m shares (~3.5% of float) | Days-to-cover ~3.9 (Jan 2026 filing date) |
| 52-week price change | ~−27% | Trailing month ~−12% |
7. What Are They Building / What’s Coming?
- FY2026 guidance (set at FY25 release): revenue growth 27–30% YoY (~$3.53–3.61bn); adjusted EBITDA margin 25.5% (~$900m); stock-based comp $590–620m; capex $185–215m.
- 2028 long-range target: ~$6bn revenue; ~28% adj. EBITDA margin; 60% EBITDA-to-FCF conversion.
- AI product ramp: Draft One monetisation (Premier tier); Axon Assistant; Axon Vision; Axon 911 (Prepared + Carbyne integration). All three new AI products launched at Axon Week 2026 (7 April).
- TASER 10 global ramp. UK Home Office approval (Oct 2025) opens UK policing deployment.
- Counter-drone / Dedrone expansion into airports, stadiums, critical infrastructure; Sky-Hero tactical robotics rollout to US agencies.
- Federal: ICE 5-year TASER program (up to $220m, 17,800 units) and ongoing DHS expansion.
- Q1 2026 earnings: Wednesday 6 May 2026, after market close (Zoom webinar 5:00pm ET).
8. Competitive Landscape
Axon is dominant in US law enforcement across every product line it plays in. Outside the US and in adjacent drone / 911 spaces the market is more fragmented.
| Category | Axon | Closest competitors |
|---|---|---|
| Body-worn cameras (US LE) | ~85% share in major US cities | Motorola Solutions (WatchGuard V300/V700) ~10–15%; Reveal Media, Getac, Visual Labs, Digital Ally low single digits |
| Conducted electrical weapons (CEW) | ~95%+ global | Byrna Technologies (pepper-ball — adjacent); Wrap Technologies / BolaWrap (tethered restraint — niche) |
| Digital evidence management | Category-defining | Motorola Solutions CommandCentral; NICE Public Safety; Veritone; Genetec Clearance |
| In-car / fleet | Axon Fleet 3 | Motorola WatchGuard; Coban (Safe Fleet); Digital Ally |
| Drones / counter-UAS | Skydio partner + Dedrone owned | Skydio (independent); DJI (US restricted); BRINC; Parrot; Anduril |
| 911 / dispatch | Axon 911 (Prepared + Carbyne) | Motorola Solutions (VESTA, CallWorks); RapidDeploy (Motorola); Intrado |
Closest pure-play public comparable: Motorola Solutions (NYSE: MSI).
9. Leadership and Ownership
Executive team: Rick Smith (Founder, Chairman, CEO — born 1969); Brittany Bagley (COO & CFO — joined Aug 2022 from Sonos, previously Bain Capital); Josh Isner (President since 2022 — former CRO); Jeff Kunins (Chief Product Officer & CTO).
Board: Director Matthew McBrady announced in April 2026 that he will not stand for re-election.
Recent insider activity (Form 4): Rick Smith reported sale of 10,000 shares on 9 March 2026 (~$6m proceeds). Brittany Bagley sold 4,266 shares at $550–$556 on 2 March 2026 (proceeds ~$2.36m); post-sale holdings 99,235 shares. Activity consistent with ongoing 10b5-1 plans rather than open-market discretionary purchases.
| Holder | Approx stake | Notes |
|---|---|---|
| Vanguard Group | ~10–11% | Largest disclosed institutional holder |
| BlackRock | ~8–9% | |
| State Street | top-10 | |
| Fidelity (FMR) | top-10 | |
| Geode Capital, Baillie Gifford, Sands Capital, Wellington, Invesco, T. Rowe Price, Capital Group | top-15 | |
| Rick Smith (Founder/CEO) | ~3.85% direct | Mid-single-digit beneficial including options |
Total institutional ownership ~80%. Shares outstanding ~82.4m.
10. Risks and Challenges
- Valuation / multiple compression. Stock −54% from 52-week high; trailing GAAP P/E ~250–310x; sensitive to growth disappointment given rich multiples.
- TASER product liability. History of wrongful-death and excessive-force suits; continued litigation risk on CEW use.
- AI / Draft One scrutiny. EFF "Axon’s Draft One Is Designed to Defy Transparency" (July 2025); ACLU criticism; California SB 524 (2026) requires AI disclosure in police narratives. No court ruling against Draft One identified as of 23 April 2026; regulatory risk is live.
- Civil-liberties / political risk. Expansion into ICE work has drawn public and municipal pushback; lobbying spend tripled from $0.48m (2020) to $2.5m (2025).
- Customer concentration. Dependence on municipal/state police budgets (recession-sensitive, politically exposed).
- Tariffs & hardware mix. Connected Devices adjusted gross margin fell ~290bps YoY in Q4 2025 to 49.3% on "product mix and global tariffs."
- Integration risk. Rapid M&A pace — Prepared (~$800m), Carbyne (~$625m), Dedrone, Sky-Hero, Fusus — elevates execution and goodwill risk.
- Federal procurement volatility. ICE/DHS ramp is additive but politically exposed.
- Competition from Motorola Solutions (deepest pockets / full stack) and international body-cam / counter-UAS upstarts.
- Founder / key-person risk on Rick Smith.
- Stock-based compensation guided to $590–620m in FY2026 — sizeable share-count dilution driver.
11. Recent Developments
- 22 April 2026 — "Axon to Release First Quarter 2026 Earnings on May 6, 2026." Q1 2026 earnings released after market close, 5:00pm ET Zoom webinar. Conference participation: Needham (12 May), BofA Industrials (13 May), J.P. Morgan TMC (19 May).
- 21 April 2026 — Stock close $404.92. −12% over the trailing month; −27% over the trailing 52 weeks; 52-week range $339.01–$885.92.
- 7 April 2026 — Axon Week 2026 (Nashville, ~3,000 attendees). Launched three AI products: Axon Vision (live-video AI triage for RTCC/911), Axon Assistant (CJIS-compliant officer copilot), Axon 911 (cloud 911 platform built on Prepared + Carbyne).
- Early April 2026. Director Matthew McBrady announced he will not stand for re-election. Stock fell >7% in one session during Axon Week. OpenSecrets analysis flagged Axon’s 2025 lobbying spend at $2.5m (+68% YoY).
- March 2026. ICE $220m, 5-year, 17,800-unit TASER procurement moved forward (Times of San Diego); Axon the sole-specification supplier.
- 9 March 2026 — Form 4: Rick Smith sold 10,000 shares (~$6m).
- 2 March 2026 — Form 4: Brittany Bagley sold 4,266 shares at $550–$556.62; post-sale holdings 99,235.
- 24 February 2026 — FY2025 / Q4 2025 earnings. Revenue $797m Q4 (+39%); full-year $2.78bn (+33%); ARR $1.35bn (+35%); future bookings $14.4bn; FY2026 guide 27–30% growth; 2028 target $6bn revenue.
- 4 November 2025 (Q3). Announced Carbyne acquisition (~$625m), following Prepared (~$800m, September 2025). Together these form Axon 911.
- October 2025. UK Home Secretary approved TASER 10 for UK policing deployment.
- 2024–25. Completed acquisitions of Dedrone (counter-UAS), Sky-Hero (tactical robotics) and Fusus (real-time operations).
12. Key Dates Coming Up
- 6 May 2026 (Wed) — Q1 2026 earnings release, after market close; Zoom webinar 5:00pm ET.
- 12 May 2026 — Needham Technology, Media & Consumer Conference.
- 13 May 2026 — BofA Industrials, Transportation & Airlines Key Leaders Conference.
- 19 May 2026 — J.P. Morgan Global Technology, Media & Communications Conference.
- ~May 2026 — 2026 Annual Meeting of Stockholders (date not yet disclosed; historical pattern May).
- ~early August 2026 — Q2 2026 earnings (estimated).
- ~early November 2026 — Q3 2026 earnings (estimated).
- ~late February 2027 — FY2026 / Q4 2026 earnings (estimated).
Related
For live charts and watchlists, see our live charts. US macro and Fed events that move high-multiple software/hardware names are on the economic calendar. Discuss this report in the community forum, and browse more company research on the blog.
Disclaimer: Research only. This article is for information and discussion purposes. It is not investment advice, not a recommendation to buy or sell any security, and does not take your personal circumstances into account. All financial figures come from Axon Enterprise SEC filings, earnings releases and press releases; market data is as of the dates stated. Always do your own research and consult a qualified adviser before making investment decisions.
Loading research report…
13. Thesis Verdict
The central thesis. Axon operates an integrated public-safety ecosystem combining hardware (TASER 10, Axon Body 4, drones, counter-UAS) with cloud software (Axon Evidence, Records, Respond) sold to law enforcement, federal agencies and corrections on 5-year bundled "Officer Safety Plans". FY2025 revenue reached $2.78bn (+33%), with Software & Services at $1.20bn (+40%), ARR of $1.35bn (+35%), net revenue retention of 125%, and future contracted bookings of $14.4bn (+43%). Category leadership is entrenched (~95% global CEW share, ~85% body-worn camera share in major US cities). Near-term catalysts include Q1 2026 earnings on 6 May, the FY2026 guide of 27–30% revenue growth, monetisation of newly launched AI products (Draft One, Axon Assistant, Axon Vision, Axon 911), and federal ramp including the ICE 5-year TASER procurement.
What would confirm or break it. Confirmation would come from sustained 27–30% revenue growth, continued ARR and bookings expansion, Connected Devices gross margin recovery from the 49.3% recorded in Q4 2025, and successful integration of Prepared and Carbyne into Axon 911. Materialisation of adverse AI regulation following California SB 524, TASER product liability outcomes, further tariff-driven hardware margin erosion, municipal pushback on ICE work, or M&A integration slippage would invalidate the growth-at-scale thesis given the trailing GAAP P/E of ~250–310x.
Watchpoints
- InvalidatesMaterialisation of the "Stock-based compensation" risk, or any disclosure that fundamentally alters the capital-return or growth profile stated by management.
- ConfirmsSubsequent earnings and filings reinforcing the figures presented in this report.
- InvalidatesAny disclosure that directly contradicts a material claim in the bull case.
Diagnostic grid
Generated by ChartsView research tooling. Thesis strength measures how well the evidence in this report supports the company's stated thesis — it is NOT a buy/sell rating or price target. ChartsView is not authorised by the FCA to provide regulated investment advice. Generated 23 Apr 2026.